Andrade, Gustavo Moreira, et al. “Capivasertib and Fulvestrant, a New Salvation for Hormone Receptor-Positive Breast Cancer? A Systematic Review”. Mastology, vol. 34, no. suppl. 1, Mar. 2026, doi:10.29289/259453942024V34S1039.